161 related articles for article (PubMed ID: 36123047)
1. Prognostic Impact of Renal Dysfunction at 1-Year Follow-Up on Clinical Outcomes After Percutaneous Coronary Intervention.
Takahashi T; Watanabe T; Aono T; Otaki Y; Wanezaki M; Nishiyama S; Kutsuzawa D; Kato S; Tamura H; Arimoto T; Takahashi H; Watanabe M
J Atheroscler Thromb; 2023 Jul; 30(7):786-794. PubMed ID: 36123047
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
[TBL] [Abstract][Full Text] [Related]
4. Impact of unprotected left main percutaneous coronary intervention on long-term clinical outcomes: a large single-center study.
Xu L; Gao Z; Song Y; Wang H; Xu J; Jiang P; Jiang L; Tang X; Chen J; Gao L; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
Coron Artery Dis; 2019 Jun; 30(4):249-254. PubMed ID: 30762624
[TBL] [Abstract][Full Text] [Related]
5. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
[TBL] [Abstract][Full Text] [Related]
6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
7. An optimal strategy for coronary revascularization in patients with severe renal dysfunction.
Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R;
Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698
[TBL] [Abstract][Full Text] [Related]
8. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):285-290. PubMed ID: 29289574
[TBL] [Abstract][Full Text] [Related]
10. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
Deguchi Y; Saito Y; Nakao M; Shiraishi H; Sakamoto N; Kobayashi S; Kobayashi Y
Heart Vessels; 2021 Mar; 36(3):315-320. PubMed ID: 32930865
[TBL] [Abstract][Full Text] [Related]
11. Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI.
Dai XY; Zheng YY; Tang JN; Wang W; Guo QQ; Yin SS; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34121126
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, future cardiac events, and prognostic factors following percutaneous coronary intervention in young female patients.
Tatami Y; Tanaka A; Ohashi T; Kubota R; Kaneko S; Shinoda M; Uemura Y; Takagi K; Tanaka M; Umemoto N; Tashiro H; Shibata N; Yoshioka N; Watarai M; Morishima I; Takada Y; Shimizu K; Ishii H; Murohara T;
Heart Vessels; 2024 Jun; 39(6):505-513. PubMed ID: 38411632
[TBL] [Abstract][Full Text] [Related]
13. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.
Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
Atherosclerosis; 2017 Oct; 265():35-40. PubMed ID: 28843126
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.
Liu TD; Zheng YY; Tang JN; Wang W; Dai XY; Zhang JC; Guo QQ; Cheng MD; Song FH; Fan L; Liu ZY; Zhang ZL; Bai Y; Wang K; Yue XT; Zheng RJ; Zhang JY
Clin Appl Thromb Hemost; 2022; 28():10760296221103271. PubMed ID: 36001005
[TBL] [Abstract][Full Text] [Related]
15. Improved Renal Function After Percutaneous Coronary Intervention in Non-Dialysis Patients With Acute Coronary Syndrome and Advanced Renal Dysfunction.
Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Tashiro H; Umemoto N; Inoue Y; Morishima I; Shimizu K; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
Cardiovasc Revasc Med; 2021 Mar; 24():26-30. PubMed ID: 32952075
[TBL] [Abstract][Full Text] [Related]
16. Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study.
Jiang ZH; Aierken A; Wu TT; Zheng YY; Ma YT; Xie X
BMJ Open; 2023 Apr; 13(4):e067951. PubMed ID: 37015792
[TBL] [Abstract][Full Text] [Related]
17. [Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].
Song Y; Tang XF; Xu JJ; Wang HH; Liu R; Jiang P; Jiang L; Gao LJ; Zhang Y; Song L; Xu LJ; Zhao XY; Gao Z; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):108-116. PubMed ID: 30818938
[No Abstract] [Full Text] [Related]
18. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes.
Ann SH; Seo SM; Kim PJ; Koh YS; Her SH; Shin DI; Park HJ; Park CS; Lee JM; Kim DB; Chang K; Chung WS; Seung KB
Cardiol J; 2016; 23(6):637-646. PubMed ID: 27665858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
